CRVSCorvus Pharmaceuticals, Inc.
$10.52+79% 1Y
$10.52
$6.0452 weeks$25.52
The financials
Corvus Pharmaceuticals, Inc. by the numbers
The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$19M | −$10M | n/a |
| Net income | −$18M | −$8.0M | n/a |
| Diluted EPS | −$0.19 | −$0.10 | n/a |
On our screens:Most shorted stocks